- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder
Nonadherence is a serious problem that can compromise treatment effectiveness in psychiatry. This presentation will review the multidimensional factors that contribute to adherence, discuss consequences of poor adherence, and bring to light implementation strategies to address adherence.
Featuring
-
Larry Reccoppa, MD
Regional Psychiatric Director, Wellpath; Staff Psychiatrist, Behavioral Health Services CMHC
-
Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison
-
Aneta Fornal, PharmD (OPDC)
Medical Science Liaison
Speaker Larry Reccoppa, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers Jacquelyn Canning, PharmD, BCPP and Aneta Fornal, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Register
This event registration is closed.